Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2026)

Adaptive Biotechnologies has reported Inventory Average for 8 years, with the latest figure at $10.5 million in Q1 2026.

• Quarterly Inventory Average rose 22.79% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 22.79% YoY) and the FY2025 annual result came in at $9.1 million, down 20.22% from the prior year.
• Inventory Average advanced to $10.5 million in Q1 2026 per ADPT's latest filing, from $9.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $20.1 million in Q1 2022 and troughed at $8.5 million in Q2 2025.
• A 5-year average of $14.3 million and a median of $13.9 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2024: Inventory Average increased 27.89% in 2022, then plunged 39.91% in 2024.
• Over 5 years, Inventory Average stood at $15.9 million in 2022, then gained by 6.73% to $17.0 million in 2023, then slumped by 39.91% to $10.2 million in 2024, then slipped by 3.15% to $9.9 million in 2025, then grew by 6.44% to $10.5 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $10.5 million, $9.9 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.